Fleur Chandler | Therapy Area Head of Respiratory Value Evidence and Outcomes
GlaxoSmithKline Biologicals

Fleur Chandler, Therapy Area Head of Respiratory Value Evidence and Outcomes, GlaxoSmithKline Biologicals

Appearances:



Day 2 Orphan 15th Nov @ 14:10

A panel discussion on an innovative and groundbreaking collaborative approach to approaching HTA in rare disease

Project HERCULES: A platform to share evidence to HTAs – a model for DMD and beyond

back to speakers